Brazil

Last Updated 5 March 2021.

4 Vaccines Approved for Use in Brazil

• Pfizer/BioNTech
  BNT162b2

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 68 countries

  12 trials in 9 countries

  RNA

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 68 countries

  22 trials in 13 countries

  Non Replicating Viral Vector

• Serum Institute of India
  Covishield

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 17 countries

  2 trials in 1 country

  Non Replicating Viral Vector

• Sinovac
  CoronaVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 16 countries

  11 trials in 5 countries

  Inactivated

6 Vaccines in Clinical Trials in Brazil

• Clover
  SCB-2019

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 3 trials.

  3 trials in 10 countries

  Protein Subunit

• Pfizer/BioNTech
  BNT162b2

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 68 countries

  12 trials in 9 countries

  RNA

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 4 other countries

  8 trials in 17 countries

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 68 countries

  22 trials in 13 countries

  Non Replicating Viral Vector

• Chinese Academy of Medical Sciences
  Inactivated (Vero Cells)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 3 trials.

  5 trials in 3 countries

  Inactivated

• Sinovac
  CoronaVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 16 countries

  11 trials in 5 countries

  Inactivated